CLINICAL TRIALS & ALASTA™

In placebo-controlled and double-blind studies conducted by an independent laboratory, Alasta™ has been clinically proven to help improve skin elasticity and firmness up to 61 percent in only 12 weeks of use when taken orally and up to 72 percent in only 8 weeks of use when used topically. These results are statistically significant, and the placebo group did not show a significant improvement.

In the study on Alasta™ as an oral supplement for skin elasticity, Cutometer instrumentation was used to measure and estimate several variables, including elastic, viscoelastic and purely viscous behavior of the skin. In the topical application study, skin firmness (elasticity) scores were obtained using the Pinch Test method.


 

Study and study type


alasta™

oral supplement for skin elasticity

 

Study Duration (weeks)

12

Participants (number)

20

Summary of alasta™ Clinical Studies


In the placebo-controlled, double-blind study, 70% of subjects demonstrated up to 61% improvement in skin elasticity and distensibility. The results were statistically significant and the placebo group showed no significant improvement.

 

 
alasta™
topical application for skin elasticity
8 30 In the placebo-controlled, double-blind study, 100% of subjects demonstrated up to 72% improvement in skin elasticity over baseline. The results were statistically significant and the placebo group showed no significant improvement.